Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hematopoietic stem cell transplantation (low intensity stem cell transplantation) was associated with improvement in measures of disability and quality of life, according to a study in the January 20 issue of JAMA.
from The Medical News http://ift.tt/1yq4H8t
from The Medical News http://ift.tt/1yq4H8t
No comments:
Post a Comment